Author

Karsten Tillack

Evotec (Germany)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alberto Ambesi‐ImpiombatoiD· 1 shared Brenda Lager· 1 shared Christopher HartliD· 1 shared Daniela BrunneriD· 1 shared David HowlandiD· 1 shared Deanna M. MarchioniniiD· 1 shared Ethan R. Signer· 1 shared Finn PetersiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alberto Ambesi‐ImpiombatoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model

Deanna M. Marchionini, Jeh-Ping Liu, Alberto Ambesi‐Impiombato, Kimberly Kerker, Kim Cirillo, Mukesh Bansal, Rich Mushlin, Daniela Brunner, Sylvie Ramboz, Mei Yee Kwan, Kirsten Kuhlbrodt, Karsten Tillack, Finn Peters, Leena Rauhala, John C. Obenauer, , Scott O. Zeitlin

This study shows that moderate global lowering of mutant Huntingtin in a HD mouse model delays some deficits but benefits diminish over time, suggesting long-term mHtt lowering may be needed for sustained benefit.

JCI Insight · Oct 23, 2022Peer-reviewedNeuroscience